PT  - JOURNAL ARTICLE
AU  - Chen, Yiran
AU  - Volić, Ismar
TI  - Topological data analysis model for the spread of the coronavirus
AID  - 10.1101/2020.08.13.20174326
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.13.20174326
4099  - http://medrxiv.org/content/early/2020/08/14/2020.08.13.20174326.short
4100  - http://medrxiv.org/content/early/2020/08/14/2020.08.13.20174326.full
AB  - We apply topological data analysis, specifically the Mapper algorithm, to the U.S. COVID-19 data. The resulting Mapper graphs provide visualizations of the pandemic that are more complete than those supplied by other, more standard methods. They encode a variety of geometric features of the data cloud created from geographic information, time progression, and the number of COVID-19 cases. They reflect the development of the pandemic across all of the U.S. and capture the growth rates as well as the regional prominence of hot-spots. The Mapper graphs allow for easy comparisons across time and space and have the potential of becoming a useful predictive tool for the spread of the coronavirus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding for this research was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no need for approval for the research provided here since it only uses data that is publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is publicly available online. https://systems.jhu.edu/research/public-health/ncov/